EUVIMEDEUVIMED entdecken
Fallbericht

Sweat Gland Carcinoma With Neuroendocrine Differentiation ( SCAND ) Harboring a Novel GATA3 Frameshift Extension Mutation: A Case Study With Protein Structural Modeling

Myles R McCrary iD, Pei-Ling Chen, Jane L Messina

Journal of Cutaneous Pathology · 2026

DOI: 10.1111/cup.70088 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, 2026. Verfasst von Myles R McCrary und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA. Hauptthemen laut MEDLINE: GATA3 Transcription Factor, Frameshift Mutation, Sweat Gland Neoplasms, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sweat‐gland carcinoma with neuroendocrine differentiation (SCAND) is a rare cutaneous adnexal carcinoma. Here we report a case of aggressive SCAND originating in the suprapubic area of an elderly male with lung and spinal cord metastasis. Sections from an excisional biopsy showed an infiltrative neoplasm filling the dermis with extension into the subcutaneous fat. Immunohistochemical studies showed expression of neuroendocrine markers, resulting in an initial diagnosis of metastatic neuroendocrine carcinoma. Next‐generation sequencing identified a novel GATA3 frameshift extension mutation (p.F410Hfs), consistent with SCAND. Structural modeling showed the mutation in the final exon to result in an extended C‐terminal domain and altered protein structure similar to other cases. We hypothesize the C‐terminal protein extension may affect interactions with the adjacent zinc finger domain, potentially influencing transcriptional activity. This case expands the molecular spectrum of SCAND and supports its recognition as a distinct clinicopathologic entity. Recognition of the distinct histopathologic and molecular features aids in the diagnosis of this emerging entity, which appears to carry a poor prognosis. Further studies are needed to better understand the oncogenic role of the GATA3 extension mutations and to establish optimal management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GATA3 Transcription FactorFrameshift MutationSweat Gland NeoplasmsCarcinoma, NeuroendocrineHumansMaleAgedCell DifferentiationModels, Molecular

Stichwörter der Autor:innen

cutaneous adnexal malignancyprimary cutaneous low grade neuroendocrine carcinomasweat gland carcinoma with neuroendocrine differentiation

Substanzen

GATA3 Transcription FactorGATA3 protein, human

Autor:innen und Institutionen

  • Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
  • Department of Pathology, Moffitt Cancer Center, Tampa, Florida, USA.

ORCID-Profile: Myles R McCrary

Zitieren

APA

McCrary, M. R., Chen, P. L., & Messina, J. L. (2026). Sweat Gland Carcinoma With Neuroendocrine Differentiation ( SCAND ) Harboring a Novel GATA3 Frameshift Extension Mutation: A Case Study With Protein Structural Modeling. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.70088

Vancouver

McCrary MR, Chen PL, Messina JL. Sweat Gland Carcinoma With Neuroendocrine Differentiation ( SCAND ) Harboring a Novel GATA3 Frameshift Extension Mutation: A Case Study With Protein Structural Modeling. Journal of Cutaneous Pathology. 2026. doi:10.1111/cup.70088

BibTeX
@article{McCrary2026,
  author = {McCrary, Myles R and Chen, Pei-Ling and Messina, Jane L},
  title = {Sweat Gland Carcinoma With Neuroendocrine Differentiation ( SCAND ) Harboring a Novel GATA3 Frameshift Extension Mutation: A Case Study With Protein Structural Modeling},
  journal = {Journal of Cutaneous Pathology},
  year = {2026},
  doi = {10.1111/cup.70088}
}
Kostenlos starten →